Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (141)	6/30/2006 11:34:05 AM
From: DewDiligence_on_SI	Read Replies (1) of 3027

Copaxone accounted for nearly 30% of teva's sales in q1, how can it comprise just 15% of profits at branded margins? You’re double counting (among other errors). TEVA splits Copaxone 50/50 with SNY. TEVA’s share of 1Q06 Copaxone sales was $165M, which was 9.8% of TEVA’s overall 1Q06 sales of $1.67B.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next